Democritus University of Thrace (DUTH)
Comparative study of the regulatoty role of probiotic microoganisms in homeostasis and cell function
Abstract
dc:descriptionProbiotics are live microorganisms, that when consumed in adequate amounts exert health benefits to the host. Although this definition is relatively recent, the use of probiotics has been practiced for centuries, oftentimes unknowingly. Ancient civilizations utilized them to ferment excess raw materials and produce novel foodstuffs with enhanced safety and organoleptic characteristics. At the same time, these products held great significance in traditional medicine, particularly in treating gastrointestinal (GI) diseases. Advancements in the microbiology field have supported the isolation and assessment of the properties of microorganisms found in these traditional fermented products. For a novel isolate to be characterized as probiotic a series of safety and functional criteria should be met. Firstly, it should be sensitive to common antibiotics and not carry transferable antibiotic resistance genes. Additionally, it must withstand host-related stresses, and be capable of at least, transiently colonizing the GI tract of the consumer. Whole genome sequencing (WGS) is also required for strains intended for use in the food chain. Common probiotic microorganisms include lactic acid bacteria (LAB), such as Lactobacillus spp., Bifidobacterium spp., and yeasts (i.e. Sacharomyces spp). Probiotic lactobacilli are Gram-positive, fastidious, non-motile, microorganisms that can be isolated from diverse sources; fermented products, environmental or host-associated niches. In the context of the host, lactobacilli predominantly colonize the small intestine and vagina. Reduction in their abundance has been linked to several intestinal and extraintestinal diseases, including inflammatory and functional disorders of the gut, localized and systemic infections, cancer and neurodegenerative diseases. The capacity of ingested lactobacilli to prevent or reverse these outcomes is a topic of intense research. Today, available preclinical and clinical data suggests that lactobacilli can exert strain-, host- and disease- specific activity. However, the molecular basis for these outcomes is not fully understood. The development and application of genomic and multi-omics methodologies has provided insight into their evolutionary history, probiotic and biotechnological potential. In this context, the accumulation of available WGS has led to the recent reclassification of the former Lactobacillus genus. Accordingly, transcriptomics and proteomics have supported the study of the probiotic character at multiple levels to generate mechanistic insight into lactobacilli-microbe and lactobacilli-host interactions. The aim of the present thesis was to investigate the strain-specific capacity of lactobacilli to affect cellular function and homeostasis, utilizing multi-disciplinary approaches. Lactiplantibacillus pentosus L33 (L33), Lactiplantibacillus plantarum L125 (L125) and Lacticaseibacillus paracasei SP5 (SP5) are three wild-type LAB strains, which have been previously isolated from fermented sausages and kefir grains, respectively. They were shown to exhibit basic probiotic attributes in vitro, including resistance to simulated GI tract conditions, sensitivity to common antibiotics and lack of hemolytic activity. Additionally, SP5 exhibits robust biotechnological potential, and has been incorporated into several dairy and non-dairy fermented products. The WGS of strains L33 and L125 have been previously published by our group. Lacticaseibacillus rhamnosus GG (LGG) and Lacticaseibacillus casei ATCC 393 (Lc393), two commercially available probiotic strains, were also incorporated in this study. Firstly, WGS was performed for SP5 to annotate genes involved in the probiotic and biotechnological potential of the strain. The strain carries a genome with a total length of 2,958,982 bp and a GC content of 46.3%. It does not contain plasmids or transposable elements, acquired antibiotic resistance genes or virulence factors. The nomadic character of the strain is reflected in the numerous clusters for carbohydrate transport and utilization, and in the lack of amino acid biosynthetic modules. To compensate for the lack of these clusters the strain carries extensive proteolytic systems. Furthermore, modules for thiamine and γ-aminobutyric acid (GABA) production were identified in the genome of the strain. Comparative pangenomics were utilized to investigate niche preference in lactobacilli. To this aim, the genome sequences of prominent free-living, host-associated and nomadic strains were analyzed. Shared genes between the three groups code for housekeeping, conserved functions, such as amino acid synthesis, carbohydrate metabolism and DNA repair mechanisms. Finally, pangenome-wide association analysis was performed to correlate niche preference with specific genetic loci. To this end, two hypothetical proteins were correlated with adaptation of Lp. plantarum strains in insect hosts. Probiotic lactobacilli can exert antimicrobial and antibiofilm activity against foodborne and clinically relevant pathogens, in a strain-specific manner. Specifically, matrix acidification, as well as the secretion of bacteriocins or of other small antimicrobial, including quorum quenching (QQ) molecules contribute to these phenotypes. At the same time, cell surface components may exert direct antimicrobial activity or participate in events of competitive exclusion from host mucosa. Furthermore, lactobacilli can trigger pathogen clearance mechanisms. In this context, the antimicrobial activity of the five strains against Staphylococccus aureus, Salmonella enterica and Escherichia coli, was examined in silico and in vitro. The WGS of the wild-type strains was searched for the presence of bacteriocins, and of other antimicrobial peptides. Comparative genomics were utilized to infer their functionality. Putative bacteriocins with high sequence and structural identity to functional peptides were identified in the genome of strains L33, L125 and SP5. The expression levels of these peptides were shown to be upregulated in co-incubation with specific pathogens. Next, the capacity of viable lactobacilli or their cell-free culture supernatant (CFCS) to inhibit pathogen viability and biofilm formation capacity was determined with microbiological methods and confocal microscopy. It was found that the unfractionated CFCS limited pathogen viability in a dose- and pH-dependent manner. Additionally, small peptides produced by the three wild-type strains were effective against S. aureus. Lactobacilli CFCS effectively limited biofilm mass and viability, with the higher inhibition being recorded for Lc. paracasei SP5 CFCS against S. enterica biofilms (>2.5 log reduction). These effects were attributed to the cytotoxic activity of the CFCS and the capacity of the lactobacilli-derived metabolites to modulate the expression of key genes involved in biofilm formation, in a pathogen-specific manner. Then, we sought to determine whether the lactobacilli that present direct antimicrobial activity can prevent infection in a cellular model. S. aureus and E. coli were found to exert cytotoxic effects in co-incubation with the human adenocarcinoma cell line HT-29 in a time-dependent manner. The capacity of the lactobacilli to prevent pathogen-induced cell death was examined in silico and in vitro. Among the tested strains, only L125 could prevent the detrimental effects of infection when in direct contact with the cells for 4h prior to pathogen challenge. These effects were comparable to those induced by LGG, a strain with well-documented capacity to limit S. aureus-induced cell death. The protective phenotype was attributed to the capacity of strain L125 to code for cell surface proteins that could participate in competitive exclusion events. Dual RNA-seq and protein microarrays were used to further explore this phenotype. Indeed, several L125 adhesins and moonlighting proteins were expressed in high levels during co-incubation with HT-29 cells. At the same time, pathways involved in actin rearrangement, endocytosis, pathogen adherence and invasion were downregulated in host cells. These findings suggest Lp. plantarum L125 can exclude pathogens from the host cell surface and prime resistance mechanisms to combat infection. In the context of the thesis, a novel method for the strain-specific identification of bacteria of interest with available WGS was developed. Specifically, unique genomic regions were identified with comparative genomics and used for primer design. The specificity of the generated primer sets was validated in silico and in vitro. In vitro, the primer sets are incorporated in multiplex PCR to produce a unique electrophoretic pattern for the target strain. Our group has successfully applied this method to detect strains L33, L125 and Lc. paracasei SRX10 in monocultures and fermented foodstuffs. Finally, our group developed Probio-ichnos, (probiotic + ichnos, or fingerprint in Greek), a manually curated, literature-based database for bacteria and fungi with in vitro probiotic attributes. As the number of available studies on probiotic microorganisms is increasing at an exponential rate, tools contributing to the comprehensive study of their properties have become indispensable. To this end, Probio-ichnos collects and comprehensively presents data on seven basic in vitro probiotic characteristics: survival in the GI tract, adherence capacity, antimicrobial, immunomodulatory, antiproliferative and antioxidant activity, for strains derived from diverse niches. Currently, the database contains 12,993 entries, for 11,202 strains belonging to 407 species and 143 genera, and 789 WGS. Probio-ichnos aims at supporting basic and applied research, as it facilitates comparative analysis between probiotics of interest and the identification of gaps or discrepancies in current literature. Overall, in this thesis the probiotic potential of three wild-type LAB stains isolated from fermented products was examined at greater depth, utilizing multidisciplinary approaches, including comparative genomics, pangenomics, microbiological assays, confocal microscopy, and omics platforms. At the same time, the probiotic profile of the two commercial probiotic strains, LGG and Lc393 was expanded. Finally, a novel method for bacterial identification at the strain level in complex samples, and a comprehensive database for strains with in vitro properties were developed. Future studies will focus on the validation of the strain-specific capacity of L125 to limit pathogen-induced cell death, utilizing complex in vitro (e.g. intestinal organoids) and in vivo (e.g. gnotobiotic mice) systems that incorporate microbial communities. Additionally, the application of lactobacilli CFCS as a decontamination means will be explored in situ.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kiousi, Despoina-Evgenia
- Κιούση, Δέσποινα-Ευγενία
Subjects
dc:subject × 18- Προβιοτικοί μικροοργανισμοί
- Λακτοβάκιλλοι
- Αντιμικροβιακή δράση
- Κυτταρική λειτουργία
- Εντεροπαθογόνα
- Ομικές τεχνολογίες
- Probiotic microorganisms
- Lactobacilli
- Antimicrobial activity
- Cellular function
- Enteropathogens
- Omics technologies
- Βιολογία
- Φυσικές Επιστήμες
- Βιολογία, διεπιστημονική προσέγγιση
- Biological Sciences
- Natural Sciences
- Biology, interdisciplinary
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58005